|
|
|
Sunday, March 8, 2009 — 8:30 AM, Convention Center BRC
|
- Diagnostic Challenges in Dysproteinemias
|
|
Moderators:
|
Tibor Nadasdy, The Ohio State University Medical Center, Columbus, OH and
Maria Picken, Loyola University Chicago, Loyola University Medical Center, Maywood, IL
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
| 8:30 | Nonamyloidotic Monoclonal Immunoglobulin Deposition Disease, Randall Type - Guillermo Herrera, Nephrocor, Tempe, AZ |
| 9:15 | Proliferative Glomerulonephritis with Monoclonal IgG Deposits Mimicking Immune-Complex Glomerulonephritis - Samih Nasr, Columbia Presbyterian Medical Center, New York, NY |
| 10:00 | Break |
| 10:30 | Molecular Diagnosis of Amyloidosis - Alan Solomon, University of Tennessee School of Medicine, Knoxville, TN |
| 11:15 | Cryoglobulinemia Related Renal/Glomerular Changes - Franco Ferrario, San Carlo Borromeo Hospital, Milan, Italy |
|
The Program Committee considered potential themes of interest to practicing pathologists/nephropathologists, that had not been presented in the last five years at the RPS Companion Meetings. After lengthy discussions, the members of the program committee agreed that this was the best topic for the 2009 meeting. Diagnosing dysproteinemia related diseases in renal biopsy specimens can be very challenging and, in recent years, numerous important new studies and observations have been published. A review and update on the diagnosis and differential diagnosis on dysproteinemias is timely and will provide pathologists with further understanding of the relevance of monoclonal immunoglobulins in the pathogenesis of renal diseases.
|
|
|
|
